Incyte (INCY) Announces Data on Monjuvi, FDA Approval for GVHD Drug
https://www.zacks.com/stock/news/2323425/incyte-incy-announces-data-on-monjuvi-fda-approval-for-gvhd-drug?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2323425
Aug 16, 2024 - Incyte???s (INCY) late-stage study on tafasitamab for patients with relapsed or refractory follicular lymphoma meets its goal. FDA approves axatilimab for the treatment of chronic graft-versus-host disease.
0
Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System
https://www.zacks.com/stock/news/2306186/agilent-a-boosts-dcg-segment-with-new-proteoanalyzer-system?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2306186
Jul 22, 2024 - Agilent (A) unveils its new ProteoAnalyzer system in a bid to strengthen its Diagnostics and Genomics Group segment.
0
INCY or MYGN: Which Is the Better Value Stock Right Now?
https://www.zacks.com/stock/news/2304678/incy-or-mygn-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2304678
Jul 18, 2024 - INCY vs. MYGN: Which Stock Is the Better Value Option?
0